Abstract
Breast cancer survivors often experience hot flashes, whether from chemotherapy-induced or spontaneous menopause or from treatment with antiestrogen agents (tamoxifen, raloxifene, or aromatase inhibitors). Because hormone therapy is contraindicated in this setting, nonhormonal treatment options are particularly important for these women (see also Journal Watch Women’s Health Oct 18 2005). In this partially industry-supported trial, investigators examined …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
